As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Single-stock ETFs have been soaring, with many more than doubling in value over the past month amid the historic Wall Street comeback. Unlike traditional ETFs, which typically track a broad index or ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.